JPMorgan Chase & Co’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-45
| Closed | -$29 | – | 6665 |
|
|
2024
Q4 | $29 | Buy |
45
+14
| +45% | +$9 | ﹤0.01% | 6170 |
|
|
2024
Q3 | $12 | Buy |
+31
| New | +$12 | ﹤0.01% | 6213 |
|
|
2023
Q4 | – | Sell |
-100,557
| Closed | -$835K | – | 6779 |
|
|
2023
Q3 | $835K | Hold |
100,557
| – | – | ﹤0.01% | 3490 |
|
|
2023
Q2 | $1.04M | Sell |
100,557
-100,000
| -50% | -$1.03M | ﹤0.01% | 3418 |
|
|
2023
Q1 | $2.03M | Sell |
200,557
-234,433
| -54% | -$2.38M | ﹤0.01% | 3027 |
|
|
2022
Q4 | $4.33M | Buy |
434,990
+334,433
| +333% | +$3.33M | ﹤0.01% | 2487 |
|
|
2022
Q3 | $980K | Hold |
100,557
| – | – | ﹤0.01% | 3375 |
|
|
2022
Q2 | $976K | Hold |
100,557
| – | – | ﹤0.01% | 3491 |
|
|
2022
Q1 | $975K | Buy |
100,557
+92,320
| +1,121% | +$895K | ﹤0.01% | 3635 |
|
|
2021
Q4 | $80K | Hold |
8,237
| – | – | ﹤0.01% | 4912 |
|
|
2021
Q3 | $80K | Buy |
+8,237
| New | +$80K | ﹤0.01% | 4813 |
|